View Author
patient treatment tumor response 177 lu-octreotate lesion neuroendocrine therapy liver lu-octreotate study somatostatin metastase pancreatic month neuroendocrine tumors receptor bone lesions group 177 lu-dotatate criteria disease survival bone metastases surgery 90 y-dotatoc insulinoma calcium liver metastases level cancer imaging j clin oncol radionuclide serum analog effect peptide y-dotatoc lu-dotatate octreotide hypoglycemia soft-tissue lesions cycle krenning ep recist baseline chapter serum calcium levels result metastatic oncol j nucl med krenning table kwekkeboom dj toxicity combination follow-up progression kwekkeboom grade serum calcium level tumours jong m gastroenteropancreatic neuroendocrine tumors radiolabeled somatostatin analogs gepnet soft-tissue pancreatic neuroendocrine tumors uptake trial tumor response radiolabeled herder ww lu-dota figure ënten somatostatin receptor scintigraphy pancreas
5 Most Recent Publications
|
177Lu-octreotate in Neuroendocrine Tumors: Treatment Effects
(Doctoral Thesis)
Vliet, E.I. van |
2013-05-29
|
|
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
(Article)
Bergsma, H. Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Herder, W.W. de Peeters, R.P. Krenning, E.P. Kwekkeboom, D. |
2012-12-01
|
|
Tumor response assessment to treatment with [
177Lu-DOTA
0,Tyr
3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: Differential response of bone versus soft-tissue lesions
(Article)
Vliet, E.I. van Hermans, J.J. Ridder, M.A.J. de Teunissen, J.J.M. Kam, B.L. Krijger, R.R. de Krenning, E.P. Kwekkeboom, D. |
2012-09-01
|
|
Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
(Article)
Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Jong, M. de Krenning, E.P. Kwekkeboom, D. |
2012-01-10
|
|
Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy
(Article)
Schaik, E. van Vliet, E.I. van Herder, W.W. de Feelders, R.A. Krenning, E.P. Khan, S. Kamp, K. Valkema, R. Nederveen, F.H. van Teunissen, J.J.M. Kwekkeboom, D.J. |
2011-11-01
|
